Akili reports first public full-year earnings as it focuses on ADHD
Earlier this year, the prescription digital therapeutics company said it would put programs related to cognitive health outside of ADHD on hold.
Earlier this year, the prescription digital therapeutics company said it would put programs related to cognitive health outside of ADHD on hold.
Go to Source
2023-03-08 22:10
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
